CRISPR Gene Editing Market: By Product & Service (Therapeutics (In Vivo, Ex Vivo), Research Tools (Kits, Enzymes, Libraries), Services (CRO/CDMO)); Technology (CRISPR-Cas9, Cas12/Cas13, Base Editing, Prime Editing); Delivery (Viral Vectors, Lipid Nanoparticles, Electroporation); Application (Therapeutic Development, Drug Discovery, Agricultural Biotechnology, Diagnostics, Basic Research); End User (Biopharma, Academic & Research Institutes, CROs/CDMOs, Hospitals)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026–2035
The CRISPR gene editing market is estimated at USD 4 billion in 2025 and is projected to reach USD 22 billion by 2035, growing at a CAGR of 18.6% over the forecast period 2026–2035. Read More
We Are Trusted By These Great Companies!
Last Updated: 03-Aug-2026 | Format: | Report ID: AA08261921